New filler gel aims to restore midface fullness

NCT ID NCT07359079

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new injectable gel made from hyaluronic acid to correct volume loss in the midface area. It involves 356 adults with mild to severe midface deficiency. Participants receive either the new gel or a standard filler, and results are measured at 6 months for safety and effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

PEGDE-crosslinked hyaluronic acid hydrogel

What this could lead to

If successful, this could offer a new, safe option for restoring midface fullness and contour.

What could go wrong

This is a non-inferiority trial, so the new gel may not be better than existing fillers. Results are based on cosmetic improvement at 6 months, and individual results may vary.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THE CORRECTION OF MIDFACE VOLUME DEFICIENCY AND/OR MIDFACE CONTOUR DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chinese Academy of Medical Sciences & Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 100000, China